Experiment 1185666
Compounds isolated
Alerts
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | MATSUI,Y: OSHIMA,S: KADO,M: NAKAYAMA,M: SHIMOKATA,K: SAKAI,S: ITO,F: CHIKATA,E: HARA,K: KANDA,T: SHIMA,K: TAKENAKA,S: HOKAMA,S: GENGA,K:. (1987). PHASE II STUDY OF ORAL VP-16-213 IN SMALL CELL LUNG CANCER.. 60(12) |
| Amount utilized | |
| Compound isolated | |
| Disease | STUDIES INVOLVING PHASE 2 TRIALS IN 56 PATIENTS WITH SMALL CELL LUNG CANCER. THE OVERALL RESPONSE WAS OBTAINED IN 17 PATIENTS. THE DOSE-LIMITING FACTOR WAS LEUKOPENIA AND THROMBOCYTOPENIA. |
| Dose amount | 200 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |